Cargando…

BCLX(L) gene therapy moderates neuropathology in the DBA/2J mouse model of inherited glaucoma

Axonal degeneration of retinal ganglion cells (RGCs) causes blindness in glaucoma. Currently, there are no therapies that target axons to prevent them from degenerating. Activation of the BAX protein has been shown to be the determining step in the intrinsic apoptotic pathway that causes RGCs to die...

Descripción completa

Detalles Bibliográficos
Autores principales: Donahue, Ryan J., Fehrman, Rachel L., Gustafson, Jenna R., Nickells, Robert W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355227/
https://www.ncbi.nlm.nih.gov/pubmed/34376637
http://dx.doi.org/10.1038/s41419-021-04068-x

Ejemplares similares